Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. - Wikidata - wikimedia - TriplyDB

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

http://www.wikidata.org/entity/Q36403544

about

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu Myeloid-derived suppressor cells: linking inflammation and cancer Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma Targeting innate immunity for neurodegenerative disorders of the central nervous system Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment Myeloid suppressor cells and immune modulation in lung cancer Macrophages and Uveitis in Experimental Animal Models Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer Reciprocal relationship between myeloid-derived suppressor cells and T cells COX-2 and PGE2-dependent immunomodulation in breast cancer Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomallei Phenotype, development, and biological function of myeloid-derived suppressor cells Immunosuppression associated with chronic inflammation in the tumor microenvironment Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected Myeloid-derived suppressor cells as regulators of the immune system Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target Coordinated regulation of myeloid cells by tumours The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis IL-17 mediated inflammation promotes tumor growth and progression in the skin Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients Subsets of myeloid-derived suppressor cells in tumor-bearing mice Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.Cancer and complement.Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activity Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.The journey from stem cell to macrophage.Pegylated arginase I: a potential therapeutic approach in T-ALL Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer Human papillomavirus e7 oncoprotein transgenic skin develops an enhanced inflammatory response to 2,4-dinitrochlorobenzene by an arginase-1-dependent mechanism.

P2860

Q21131200-A090FA8B-0EEE-4497-A512-AFEB23B92B12 Q24641811-7059A434-7152-49B1-A98B-D32EBAC2B261 Q24658240-DBE261E5-7DD3-4A38-8FF1-69A8D30A3DB1 Q24676809-50541ED5-5799-4FC1-BC48-BB08EEB16F6F Q26744219-AE061CB2-54FF-41C2-A922-117F3B808E2C Q26779184-8970958B-E39D-4244-962A-D18C8FF60F03 Q26799126-65502342-60F8-4C60-A626-DCC34BBBDABE Q26823251-3312E84B-292D-4610-831D-514A609D8283 Q26828497-5AEE960B-5C78-47AD-AB11-978B8A40E699 Q26850218-54D10EC4-0373-423A-8BC1-A2498171BFD0 Q26863418-55C8749B-A97E-4FD8-9A3C-5333F28D5BA5 Q27000664-73110509-851E-45F0-924D-7A4A190B0B0B Q27003937-2673E691-FFAE-4F53-BB5B-EEAB3211DCBA Q27003955-387FE7BA-7986-4FCE-8288-F0F09262C816 Q27305217-F6DA2743-C296-4884-BBB1-F262DB3AB86B Q28079046-717D5948-EAA1-42A3-B0EA-AA9B9B3EBAEA Q28083450-068FB12D-4033-4D98-A3AD-6CEEBAD138C9 Q28084627-2850708D-9F47-4263-AF28-B2D0467236CF Q28131637-15B9EBE4-316C-46B7-9605-5FE12ACF0C7C Q28393356-8A9E296B-BF48-4938-AD35-911E3262A414 Q28395157-5D285BB8-13EB-429D-B7D3-500A3628B926 Q28396481-55270402-2CE9-4B5C-B9AA-2790D9A0362B Q28475723-011B01DA-F123-441A-92B9-D82B74AD6E9D Q28480915-AEED9C10-8E0F-4B33-820F-A8F3DAD1BE30 Q28552532-E6A3D9E4-931E-4494-ADCF-82D7C3F75734 Q29614297-D942B7EF-9E73-467C-A709-716DC7894C63 Q30413623-5BC84425-A6DF-4431-A05B-F110AEC40E41 Q33567710-76E38489-6FD1-4AF0-8D0F-5CEB4D3A7F75 Q33567728-4B21095B-9DE8-4CF4-9B53-A2B54BE2DF25 Q33584851-E3310EDE-C438-4C19-BB86-45A520947C1A Q33606107-3A0A6AD6-D9EC-4949-8281-F69C7D853D6D Q33678308-7E5AB2E6-6294-4BC9-8B26-1379085485FB Q33697712-B2DEBFA7-BDE1-474C-8669-D572B7955335 Q33733198-DE8DB61B-F825-4838-B448-13C715141B33 Q33772651-86948A10-2691-4A5C-ABD9-3B319EC662D4 Q33817936-646FB9A8-2E20-4C9F-B257-53779046579A Q33944287-F46B5DF7-F526-447C-84F3-63B3E44B81C4 Q34017104-4AFD9249-21D0-4EB8-9012-4074E36821D9 Q34043804-961C2FF6-311F-4FC6-9B8C-5F71EC45C134 Q34052492-5C1881B5-D79B-45D6-949D-DCDEF266956F

P2860

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

http://www.wikidata.org/entity/Q36403544

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

@ast

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

@en

type

label

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

@ast

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

@en

prefLabel

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

@ast

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

@en

P1433

Q36403544-9FD0E8D3-2008-4170-9DCC-8AE687D7E744

P1476

Q36403544-FE47FDD0-4747-42A2-B270-113810F302B0

P2093

Q36403544-166F0C27-C8FB-4B40-93ED-2C524C0A0B08

Q36403544-2A5D5C8B-3FB4-49C4-9049-2CC12FB329F5

Q36403544-3CFD61F8-072C-4271-92B8-840C009B6A77

Q36403544-4FA6E7A3-8D1A-4A02-9DF9-0FC7B3DC3F55

Q36403544-696DE093-D0D6-47A7-AE12-A67C390C20E3

Q36403544-CB9A729C-7ABB-4287-A846-546A48A05263

Q36403544-E58177A8-D5B3-40A9-BDFD-99B8578AB504

Q36403544-EFC92579-F64A-4618-82B1-1C28C9DDFAF1

P2860

Q36403544-081CAE39-8DD2-4D98-A5DB-8838076C39B5

Q36403544-08E24284-55C0-4420-A9BB-CA1738ACE1DF

Q36403544-0EF919AA-5B51-4CCF-B764-E9954462511F

Q36403544-0FEEF6B0-DA5E-49AB-8557-07AD52696153

Q36403544-12AB21C1-CFFB-4588-AD73-4D50104F15ED

Q36403544-1411ABAE-8F6E-47A3-A2CD-A9E7627EB743

Q36403544-15FB2767-34F0-492A-B026-F0F89BE92613

Q36403544-2383D221-595C-4DE4-8024-94C128D2644B

Q36403544-2639665F-0E18-4735-AA1E-F64944B166ED

Q36403544-2E4DB43E-CD5F-4A6D-9165-854FD81583B5

P304

Q36403544-15CAAA6D-9609-45AF-865A-7F5B3FD95E13

P31

Q36403544-4DA1456F-EA00-4F04-80F0-DAAA63086D0E

P356

Q36403544-5A515730-BB25-41A1-B6FB-3FB65138CC66

P407

Q36403544-C4D30841-18DB-4269-944F-FC32C900E1DB

P433

Q36403544-BE7C2ECF-6B64-4472-A66A-E0984CE217B6

P478

Q36403544-D69B0C71-5FA2-4BAE-80A3-4A0BC6BF5FF8

P577

Q36403544-8CA9A191-5C85-419E-894C-EF967BC3C69A

P5875

Q36403544-C361D9DC-1BB8-40C0-9464-E0830C694384

P698

Q36403544-DF0D87C2-FD4F-4A51-8AA3-84B2BBB6EBCF

P932

Q36403544-92934052-2245-40A4-9475-B9284694C736

P356

P1433

Journal of Experimental Medicine

P1476

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

@en

P2093

Augusto C Ochoa

http://www.w3.org/2001/XMLSchema#string

Claudia P Hernandez

http://www.w3.org/2001/XMLSchema#string

David Quiceno

http://www.w3.org/2001/XMLSchema#string

Jill Gilbert

http://www.w3.org/2001/XMLSchema#string

Jovanny Zabaleta

http://www.w3.org/2001/XMLSchema#string

Juan B Ochoa

http://www.w3.org/2001/XMLSchema#string

Paulo C Rodriguez

http://www.w3.org/2001/XMLSchema#string

Steven M Dubinett

http://www.w3.org/2001/XMLSchema#string

P2860

International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44

Enhancer-mediated control of macrophage-specific arginase I expression

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

Prostanoid receptors: structures, properties, and functions

Indomethacin inhibits the accumulation of tumor cells in mouse lungs and subsequent growth of lung metastases.

Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production.

Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.

Cancer statistics, 2000.

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

P304

931-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20050715

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7578602

http://www.w3.org/2001/XMLSchema#string

P698

16186186

http://www.w3.org/2001/XMLSchema#string

P932

2213169

http://www.w3.org/2001/XMLSchema#string